80 likes | 180 Views
NQF Safe Practices Consensus Evaluation October 2003. Texas Medical Institute of Technology. Subject Matter Expert Input Instructions: PROVIDE INFORMATION REQUESTED IN TABLE PROVIDED:
E N D
NQF Safe Practices Consensus Evaluation October 2003 Texas Medical Institute of Technology • Subject Matter Expert Input Instructions: • PROVIDE INFORMATION REQUESTED IN TABLE PROVIDED: • Fill in the sections of the table on slide # 2 with your expert interpretation and answers to the questions in the shaded area. • Slide #4 was provided for overflow information that may not all fit on slide # 2. • USE SLIDE # 3 AS YOUR NQF REFERENCE RESOURCE : • The content has been taken directly from the NQF Safe Practices Consensus Report published May 2003. • PLEASE RETURN THE FORMS BY E-MAIL TO THE LEAD PERSON DEFINED IN THE BOX ABOVE. • IF YOU HAVE ANY ADDITIONAL COMMENTS, PLEASE RECORD THEM IN THE BOX TO THE RIGHT. • IF YOU HAVE ANY QUESTIONS, PLEASE CALL OR E-MAIL THE LEAD OR ASSIST PERSONS FOR THE PRACTICE DESIGNATED ABOVE. • THE LEAD PERSON IS RESPONSIBLE TO COLLECT THE INFORMATION YOU SUBMIT AND THE ASSIST PERSON IS AVAILABLE TO ASSIST YOU AND THE LEAD PERSON. Subject Matter Expert Personal Comments: • ___________________________ • ___________________________
NQF Safe Practice #14: Implement standardized protocols to prevent wrong-site or wrong-patient procedures. Fill in the table below. Use slide #4 for overflow information.
NQF Safe Practice #14: Implement standardized protocols to prevent wrong-site or wrong-patient procedures. NQF Element Evaluation Leapfrog Deliverables
NQF Safe Practice #14: Implement standardized protocols to prevent wrong-site or wrong-patient procedures.
NQF Safe Practices Consensus Evaluation October 2003 Texas Medical Institute of Technology • Subject Matter Expert Input Instructions: • PROVIDE INFORMATION REQUESTED IN TABLE PROVIDED: • Fill in the sections of the table on slide # 2 with your expert interpretation and answers to the questions in the shaded area. • Slide #4 was provided for overflow information that may not all fit on slide # 2. • USE SLIDE # 3 AS YOUR NQF REFERENCE RESOURCE : • The content has been taken directly from the NQF Safe Practices Consensus Report published May 2003. • PLEASE RETURN THE FORMS BY E-MAIL TO THE LEAD PERSON DEFINED IN THE BOX ABOVE. • IF YOU HAVE ANY ADDITIONAL COMMENTS, PLEASE RECORD THEM IN THE BOX TO THE RIGHT. • IF YOU HAVE ANY QUESTIONS, PLEASE CALL OR E-MAIL THE LEAD OR ASSIST PERSONS FOR THE PRACTICE DESIGNATED ABOVE. • THE LEAD PERSON IS RESPONSIBLE TO COLLECT THE INFORMATION YOU SUBMIT AND THE ASSIST PERSON IS AVAILABLE TO ASSIST YOU AND THE LEAD PERSON. Subject Matter Expert Personal Comments: • I agree with the recommendations. • I think that their administration should be guided by a preoperative algorithm determined by their history and physical and other workup. • Their use, dosing, and length of treatment should be standardized and incorporated into a protocol. • I am not an expert in this area and can't comment on more recent evidence.
NQF Safe Practice #15: Evaluate surgical patients for risk of an ischemic event and provide Beta Blockers for those at high risk. Fill in the table below. Use slide #4 for overflow information.
NQF Safe Practice #15: Evaluate surgical patients for risk of an ischemic event and provide Beta Blockers for those at high risk. NQF Element Evaluation Leapfrog Deliverables
NQF Safe Practice #15: Evaluate surgical patients for risk of an ischemic event and provide Beta Blockers for those at high risk.